AMAG News and Press, AMAG Pharmaceuticals Inc. From 01/18/20

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

AMAG Pharmaceuticals (NASDAQ: AMAG ) announces the initiation of a leadership transition, the decision to divest Intrarosa and Vyleesi and financial updates. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

Initiating CEO transition plan Divesting Intrarosa ® and Vyleesi ®  2020 financial guidance reflects reduction in annual operating expenses of more than  $100M and a return to positive adjusted EBITDA WALTHAM, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- AMAG ...

WALTHAM, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the 38 th  Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time), in San Fran...

WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has awarded four grants totaling nearly $300,000 ...

AMAG Pharmaceuticals, Inc. (AMAG) Q3 2019 Earnings Conference Call November 01, 2019 8:00 AM ET Company Participants Linda Lennox - Vice President, Investor Relations Bill Heiden - President & Chief Executive Officer Julie Krop - Chief Medical Officer Tony Casciano - Chief ...

AMAG Pharmaceuticals ( AMAG ) Q3 results : Revenues: $84.1M (-31.2%); Feraheme: $44.2M (+19.5%); Makena: $34.3M (-57.2%); Intrarosa: $5.6M (+12.0%). More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

AMAG Pharmaceuticals (NASDAQ: AMAG ): Q3 GAAP EPS of -$0.70 beats by $0.09 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Commercial products achieve strong revenue and market share performance Vyleesi™ (bremelanotide injection) launched nationally in September Committed to work with the FDA to keep Makena available for at-risk pregnant women Conference call scheduled for 8:00 a.m. ET...

ABBV , ABR , AIG , AMAG , ASIX , AXL , BABA , BAH , BGG , CBOE , CCJ , CL , CVX , D , FND , FTS , GSHD , HAE , HE , HMSY , HRC , IBP , IMGN , IMO , ITT , LNG , LYB , MD , MGI , MGLN , MOG.A , NWL , OPI , PBA , PNM , POR , ROLL , RUTH , SRE , STX , TP...